(AZN) AstraZeneca - Performance -7.4% in 12m
AZN performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
34.02%
#28 in Peer-Group
Rel. Strength
30.57%
#5344 in Stock-Universe
Total Return 12m
-7.38%
#102 in Peer-Group
Total Return 5y
46.09%
#37 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 27.9 |
| P/E Forward | 15.4 |
| High / Low | USD |
|---|---|
| 52 Week High | 86.41 USD |
| 52 Week Low | 62.33 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 29.09 |
| Buy/Sell Signal +-5 | 1.07 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: AZN (-7.4%) vs XLV (-4.8%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
-3.42% | 131% | 313% | 64.3 | 57.8 | 0.61 | 23.7% | -5.15% |
| NVS NYSE Novartis |
3.1% | 16.7% | 81% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| LLY NYSE Eli Lilly |
0.51% | -14.7% | 405% | 63.7 | 35.8 | 1.2 | 58.2% | 18.9% |
| NOVN SW Novartis |
0.14% | 4.1% | 53.5% | 18.4 | 13.9 | 1.36 | 8.70% | 9.2% |
| GSK NYSE GlaxoSmithKline |
-5.82% | 3.79% | 51.6% | 18.6 | 8.61 | 0.38 | -25.2% | 3.11% |
| SFZN SW Siegfried Holding |
-8.26% | -8.24% | 110% | 24.2 | 23.6 | 1.48 | -42.4% | -29.3% |
| AZN NASDAQ AstraZeneca |
-4.1% | -7.38% | 46.1% | 27.9 | 15.4 | 0.93 | 72.4% | 45.1% |
| UCB BR UCB |
5.98% | 19.9% | 66.1% | 31.1 | 22 | 1.04 | -22.4% | 39.5% |
Performance Comparison: AZN vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for AZN
| Total Return (including Dividends) | AZN | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -4.10% | 1.09% | 3.75% |
| 3 Months | 7.89% | 1.98% | 25.32% |
| 12 Months | -7.38% | -4.84% | 13.11% |
| 5 Years | 46.09% | 45.05% | 109.78% |
| Trend Score (consistency of price movement) | AZN | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -75.2% | 20.4% | 80.3% |
| 3 Months | 56.5% | -22.1% | 97.2% |
| 12 Months | -46.6% | -76.5% | 45.4% |
| 5 Years | 88.5% | 87.7% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th32.00 | -5.13% | -7.56% |
| 3 Month | %th35.00 | 5.79% | -13.91% |
| 12 Month | %th49.00 | -2.67% | -18.12% |
| 5 Years | %th81.00 | 0.72% | -30.36% |
FAQs
Does AstraZeneca (AZN) outperform the market?
No,
over the last 12 months AZN made -7.38%, while its related Sector, the Health Care Sector SPDR (XLV) made -4.84%.
Over the last 3 months AZN made 7.89%, while XLV made 1.98%.
Performance Comparison AZN vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
AZN vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -2.5% | -7.9% | 0.8% | -20% |
| US NASDAQ 100 | QQQ | -3% | -8.3% | -0.8% | -19% |
| German DAX 40 | DAX | -4.3% | -4.3% | -12% | -38% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -3.6% | -7.9% | -3% | -29% |
| Hongkong Hang Seng | HSI | -2% | -7.2% | -19.7% | -46% |
| India NIFTY 50 | INDA | -1.8% | -4.9% | 0.2% | -6% |
| Brasil Bovespa | EWZ | -1.7% | -10% | -21.2% | -15% |
AZN vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -1.1% | -7.6% | -3.7% | -32% |
| Consumer Discretionary | XLY | -1.8% | -6.1% | 8.6% | -23% |
| Consumer Staples | XLP | -1.3% | -4.5% | 0.2% | -15% |
| Energy | XLE | -5.6% | -10.9% | 4.5% | -9% |
| Financial | XLF | -1.2% | -6.8% | -1.8% | -35% |
| Health Care | XLV | -0.8% | -5.2% | 9.7% | -3% |
| Industrial | XLI | -2.6% | -7.2% | -6.1% | -32% |
| Materials | XLB | -3.3% | -7.9% | -2.8% | -13% |
| Real Estate | XLRE | -1.4% | -4% | 1.9% | -19% |
| Technology | XLK | -4.1% | -11.3% | -3.3% | -17% |
| Utilities | XLU | -1% | -5.4% | -1.6% | -29% |
| Aerospace & Defense | XAR | -3.2% | -7.9% | -17.4% | -55% |
| Biotech | XBI | -4% | -4.6% | 14.9% | 2% |
| Homebuilder | XHB | -1.2% | -10.1% | 8.7% | -11% |
| Retail | XRT | -2.6% | -5.7% | 5.4% | -17% |
AZN vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -6.1% | -10.9% | 7.08% | -3% |
| Natural Gas | UNG | -0.2% | 6.4% | 20% | -1% |
| Gold | GLD | -0.9% | -3.3% | -17.1% | -47% |
| Silver | SLV | -3.7% | -3.8% | -14.9% | -26% |
| Copper | CPER | -9% | -14.2% | -19.7% | -26% |
AZN vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 0.4% | -5.2% | 4.5% | -4% |
| iShares High Yield Corp. Bond | HYG | -1.8% | -5.4% | 2.4% | -17% |